Pharmacogenetic Information in Clinical Guidelines: The European Perspective
SourceClinical Pharmacology and Therapeutics, 103, 5, (2018), pp. 795-801
Article / Letter to editor
Display more detailsDisplay less details
Clinical Pharmacology and Therapeutics
SubjectRadboudumc 16: Vascular damage RIHS: Radboud Institute for Health Sciences
Surveys among pharmacists and physicians show that these healthcare professionals have successfully adopted the concept of pharmacogenomics (PGx).(1-3) In addition, patients are willing to consent to participate in PGx implementation studies.(4) However, the surveys also show that healthcare professionals do not frequently order or recommend a PGx test.(1,2) Among others, a frequently perceived hurdle for clinical uptake of PGx is the availability of guidelines translating PGx test results into clinical actions for individual patients.(5,6).
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.